Caplin Point Laboratories Limited was established in 1990 to manufacture a range of ointment creams and other external applications. It is one of the fastest-growing mid-cap pharmaceutical companies in India. The company focused on the emerging markets of Latin America, the Caribbean, Francophone, and Southern Africa, and is today one of the leading suppliers of pharmaceuticals in these regions with over 2800 product licenses across the globe. The company has made a foray into the regulated markets for injectables with its manufacturing facility capable of handling liquid injectables in vials, ampoules, lyophilized vials, and ophthalmic dosages. The facility is approved by US FDA, EU-GMP, ANVISA-Brazil, and INVIMA-Colombia.